Glioma targeted therapy: insight into future of molecular approaches

K Yang, Z Wu, H Zhang, N Zhang, W Wu, Z Wang… - Molecular Cancer, 2022 - Springer
Gliomas are the common type of brain tumors originating from glial cells. Epidemiologically,
gliomas occur among all ages, more often seen in adults, which males are more susceptible …

Immune checkpoint blockade in infectious diseases

MN Wykes, SR Lewin - Nature Reviews Immunology, 2018 - nature.com
The upregulation of immune checkpoint molecules, such as programmed cell death protein
1 (PD1) and cytotoxic T lymphocyte antigen 4 (CTLA4), on immune cells occurs during acute …

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

C Sordo-Bahamonde, S Lorenzo-Herrero… - Molecular Cancer, 2023 - Springer
Recent introduction of monoclonal antibodies targeting immune checkpoints to harness
antitumor immunity has revolutionized the cancer treatment landscape. The therapeutic …

Targeting co-stimulatory molecules in autoimmune disease

NM Edner, G Carlesso, JS Rush… - Nature Reviews Drug …, 2020 - nature.com
Therapeutic targeting of immune checkpoints has garnered significant attention in the area
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …

Molecular mechanisms of T cell co-stimulation and co-inhibition

L Chen, DB Flies - Nature reviews immunology, 2013 - nature.com
Co-stimulatory and co-inhibitory receptors have a pivotal role in T cell biology, as they
determine the functional outcome of T cell receptor (TCR) signalling. The classic definition of …

The TNF receptor superfamily in co-stimulating and co-inhibitory responses

LK Ward-Kavanagh, WW Lin, JR Šedý, CF Ware - Immunity, 2016 - cell.com
Cytokines related to tumor necrosis factor (TNF) provide a communication network essential
for coordinating multiple cell types into an effective host defense system against pathogens …

Roles of BTLA in immunity and immune disorders

Z Ning, K Liu, H Xiong - Frontiers in Immunology, 2021 - frontiersin.org
B and T lymphocyte attenuator (BTLA) is one of the most important cosignaling molecules. It
belongs to the CD28 superfamily and is similar to programmed cell death-1 (PD-1) and …

The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

X Yu, K Harden, LC Gonzalez, M Francesco… - Nature …, 2009 - nature.com
Here we have identified a surface protein, TIGIT, containing an immunoglobulin variable
domain, a transmembrane domain and an immunoreceptor tyrosine-based inhibitory motif …

Fc‐fusion proteins: new developments and future perspectives

DM Czajkowsky, J Hu, Z Shao… - EMBO molecular medicine, 2012 - embopress.org
Since the first description in 1989 of CD4‐Fc‐fusion antagonists that inhibit human immune
deficiency virus entry into T cells, Fc‐fusion proteins have been intensely investigated for …

Inhibitory B7-family molecules in the tumour microenvironment

W Zou, L Chen - Nature Reviews Immunology, 2008 - nature.com
The B7 family consists of activating and inhibitory co-stimulatory molecules that positively
and negatively regulate immune responses. Recent studies have shown that human and …